Barinthus Biotherapeutics Plc. Overview
Barinthus Biotherapeutics Plc. Discounted Cash Flow
DCF Analysis for BRNS.
Get informed when a big investor buys or sells
+ FollowFair Value
$1.46
Current Fair Value
$1.46
↑ 117.6% Upside
Undervalued by 117.6% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison